IFRX - InflaRx N.V. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

66.09M

Cash

25.1M

Avg Qtr Burn

-10.54M

Short % of Float

0.13%

Insider Ownership

7.34%

Institutional Own.

23.72%

Qtr Updated

03/31/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Gohibic (vilobelimab) Details COVID-19	BLA Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Vilobelimab (IFX-1) Details Skin disease/disorder, Autoimmune disease, Pyoderma gangraenosum	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INF904 (C5aR Inhibitor) Details Chronic Autoimmune and Inflammatory Diseases	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Vilobelimab (IFX-1) Details Cancer, Cutaneous squamous cell carcinoma	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
IFX-1 (vilobelimab) Details Skin disease/disorder, Hidradenitis suppurativa	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
IFX-1 (vilobelimab) Details Autoimmune disease, Antineutrophil cytoplasmic antibody-associated vasculitis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.